Structured evidence table for Olive Leaf Extract Lipid Profile Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Olive Leaf Extract Lipid Profile Meta-Analysis | 9 10 9 Despite compelling preclinical evidence, antioxidant-based interventions have not translated consistently into clinical benefit. | 3 | Sezerano Marie Louise (2026) | Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera |
| Olive Leaf Extract Lipid Profile Meta-Analysis | This narrative, integrative review addresses this gap through a mechanistically interpretive synthesis of evidence spanning in silico, in vitro, in vivo, and human clinical domains, contextualized against established pharmacological benchmarks, to define what current evidence justifies and what future clinical investigation requires. | 3 | Sezerano Marie Louise (2026) | Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera |
| Olive Leaf Extract Lipid Profile Meta-Analysis | oleifera Table 1 Evidence Tier Evidence Source Translational Relevance Tier I Clinical Evidence and Evidence Syntheses (RCTs, systematic reviews, meta-analyses) Provides human-level evidence regarding efficacy, safety, tolerability, and clinically relevant outcomes. | 3 | Sezerano Marie Louise (2026) | Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera |
| Olive Leaf Extract Lipid Profile Meta-Analysis | oleifera 11 12–14 15 16 13 17 3 18 Within this context,merits systematic reassessment. | 3 | Sezerano Marie Louise (2026) | Beyond Antioxidant Activity: Redox–Inflammatory Network Modulation as a Framework for the Multi-Organ Pharmacology of Moringa oleifera |
| Olive Leaf Extract Lipid Profile Meta-Analysis | Objective To synthesize current evidence on the effects of natural compounds on oxidative stress and angiogenic biomarkers, particularly malondialdehyde (MDA), soluble fms-like tyrosine kinase-1 (sFlt-1), and placental growth factor (PlGF), in experimental models of preeclampsia. | 4 | Putri NA (2026) | Modulation of oxidative stress and angiogenic pathways by natural compounds in experimental preeclampsia: A narrative review focusing on MDA, sFlt-1, and PlGF. |
| Olive Leaf Extract Lipid Profile Meta-Analysis | Most interventions significantly reduced MDA and sFlt-1 levels, indicating reductions in oxidative stress and anti-angiogenic activity. | 4 | Putri NA (2026) | Modulation of oxidative stress and angiogenic pathways by natural compounds in experimental preeclampsia: A narrative review focusing on MDA, sFlt-1, and PlGF. |
| Olive Leaf Extract Lipid Profile Meta-Analysis | Several compounds increased expression of PlGF and/or vascular endothelial growth factor, suggesting improved placental angiogenesis. | 4 | Putri NA (2026) | Modulation of oxidative stress and angiogenic pathways by natural compounds in experimental preeclampsia: A narrative review focusing on MDA, sFlt-1, and PlGF. |
| Olive Leaf Extract Lipid Profile Meta-Analysis | Materials and methods A narrative review was conducted of studies retrieved from PubMed, Scopus, ScienceDirect, and Web of Science (2016-2026). | 4 | Putri NA (2026) | Modulation of oxidative stress and angiogenic pathways by natural compounds in experimental preeclampsia: A narrative review focusing on MDA, sFlt-1, and PlGF. |
Source documents